The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Health Policy
This section explores national and global health policies that need reform or greater visibility. We spotlight policy gaps, highlight areas for change, and share research that can inform and shape future cancer care and delivery systems.
Can a Blood Test Detect Cancer Earlier? What to Know About Liquid Biopsy
By The Cancer News Team
A new study suggests multicancer blood tests could shift cancer diagnoses to earlier stages. Here’s what liquid biopsy is, how MCED tests work, current FDA approvals, benefits, risks, and what patients should know.
Can a Blood Test Detect Cancer Earlier? What to Know About Liquid Biopsy
By The Cancer News Team
A new study suggests multicancer blood tests could shift cancer diagnoses to earlier stages. Here’s what liquid biopsy is, how MCED tests work, current FDA approvals, benefits, risks, and what patients should know.
Can a Blood Test Detect Cancer Earlier? What to Know About Liquid Biopsy
By The Cancer News Team
A new study suggests multicancer blood tests could shift cancer diagnoses to earlier stages. Here’s what liquid biopsy is, how MCED tests work, current FDA approvals, benefits, risks, and what patients should know.
Attorney Henry T. Greely on Navigating Ethical Challenges in Precision Oncology
By The Cancer News Team
A multidisciplinary panel led by Stanford ethicist Henry T. Greely, JD, examines the ethical challenges of precision oncology, including informed consent, access disparities, privacy concerns, and real-world clinical decision-making.
Attorney Henry T. Greely on Navigating Ethical Challenges in Precision Oncology
By The Cancer News Team
A multidisciplinary panel led by Stanford ethicist Henry T. Greely, JD, examines the ethical challenges of precision oncology, including informed consent, access disparities, privacy concerns, and real-world clinical decision-making.
Attorney Henry T. Greely on Navigating Ethical Challenges in Precision Oncology
By The Cancer News Team
A multidisciplinary panel led by Stanford ethicist Henry T. Greely, JD, examines the ethical challenges of precision oncology, including informed consent, access disparities, privacy concerns, and real-world clinical decision-making.
The Effect of Changing Politics on Global Health
By The Cancer News Team
An expert-led discussion from the 2025 Binaytara Global Oncology Summit examines how shifting global politics and funding cuts are reshaping cancer care access worldwide and what it will take to close the global treatment gap.
The Effect of Changing Politics on Global Health
By The Cancer News Team
An expert-led discussion from the 2025 Binaytara Global Oncology Summit examines how shifting global politics and funding cuts are reshaping cancer care access worldwide and what it will take to close the global treatment gap.
The Effect of Changing Politics on Global Health
By The Cancer News Team
An expert-led discussion from the 2025 Binaytara Global Oncology Summit examines how shifting global politics and funding cuts are reshaping cancer care access worldwide and what it will take to close the global treatment gap.
Binaytara Nepal Healthcare Policy Debate
By The Cancer News Team
This article recaps a 2025 advocacy dialogue led by Binaytara and Dr. Binay Shah to reform Nepal’s health insurance system and expand access to cancer care.
Binaytara Nepal Healthcare Policy Debate
By The Cancer News Team
This article recaps a 2025 advocacy dialogue led by Binaytara and Dr. Binay Shah to reform Nepal’s health insurance system and expand access to cancer care.
Binaytara Nepal Healthcare Policy Debate
By The Cancer News Team
This article recaps a 2025 advocacy dialogue led by Binaytara and Dr. Binay Shah to reform Nepal’s health insurance system and expand access to cancer care.
2023 Summit on Cancer Health Disparities (SCHD)
By Editorial Team
2023 Summit on Cancer Health Disparities (SCHD)
By Editorial Team
2023 Summit on Cancer Health Disparities (SCHD)
By Editorial Team